Innovative Immunotherapy Shows Promise in Early Clinical Trial for Breast Cancer
���We are hopeful that we will be able to use this new immunotherapy instead of chemotherapy, or at least dramatically reduce the need for chemotherapy, for all types of breast cancer,��� Czerniecki said. The immunotherapy leverages dendritic cells, critical components of the immune system that normally identify infection and mobilize other elements of immunity to repel a microbial attack.